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Introduction
============

Ypt/Rab proteins are small GTP-binding proteins that localize to distinct membrane domains where they coordinate vesicle motility, cargo sorting, and SNARE-mediated fusion ([@bib39]; [@bib53]; [@bib30]; [@bib11]). Rabs function by cycling between inactive GDP-bound and active GTP-bound states ([@bib25]). Rabs are activated by guanine nucleotide exchange factors (GEFs) that eject GDP to promote GTP binding and are inactivated by GTPase-activating proteins (GAPs) that stimulate hydrolysis of the bound GTP ([@bib26]; [@bib41]; [@bib28]; [@bib4]). The Rab-GAP superfamily shares a Tre-2/Bub2/Cdc16 (TBC) domain sufficient for substrate specificity and catalytic activity ([@bib1]; [@bib28]; [@bib4]). Nevertheless, only a few Rab GAPs are known to operate on specific Rabs in vivo (as opposed to in vitro), and almost nothing is known about what happens to targets downstream when Rabs are inactivated by their cognate GAPs.

Important insights into the role of Rabs in membrane fusion have been obtained from cell-free assays of *Saccharomyces cerevisiae* homotypic vacuole fusion ([@bib51]). The vacuole is the terminal endocytic compartment equivalent to the metazoan lysosome. Vacuole fusion in vitro entails four operationally defined subreactions: priming, tethering, docking, and fusion. Priming involves ATP hydrolysis by Sec18 to activate SNAREs for docking and fusion ([@bib40]; [@bib22]; [@bib43]). Tethering is defined by formation of adhesive contacts between the participating membranes and is promoted by the vacuolar Rab GTPase Ypt7 ([@bib13]; [@bib46]). Docking entails a complex set of subreactions that occur between tethering and fusion. These subreactions require active Ypt7-GTP and its Vps-C/HOPS effector complex ([@bib34]; [@bib52]; [@bib45], [@bib46]; [@bib7]). Docking culminates with formation of a trans-SNARE complex, an essential event that probably energizes membrane fusion ([@bib14]; [@bib27]; [@bib48]; [@bib16]).

Assays of purified proteins reveal that the Rab GAP Gyp7 exhibits an in vitro preference for the vacuolar Rab Ypt7 ([@bib50]; [@bib44]). Purified Gyp7, its TBC domain, or the TBC domain of another GAP, Gyp1, inhibit in vitro homotypic vacuole fusion by arresting docking ([@bib8]; [@bib46]). However, it is unclear whether Gyp1, Gyp7, or other GAPs influence Ypt7 function in vivo ([@bib54]). We now show that Gyp7 targets Ypt7 in vivo but that Gyp7 cannot efficiently terminate Ypt7 signaling without downstream assistance from Yck3, the vacuolar casein kinase I. Moreover, we find that activated Ypt7 opposes Yck3-dependent phosphorylation of at least two Ypt7 signaling targets. We also show that one of these targets, the Vps-C/HOPS subunit Vps41, interacts directly with Ypt7 and that this interaction is essential for the stable association of the HOPS-tethering complex with Ypt7. Together with previous experiments, our results delineate a signaling pathway that renders the membrane fusion machinery highly responsive to the activation state of an upstream Rab GTPase.

Results
=======

Endogenous Gyp7 regulates vacuole fusion in vivo and in vitro
-------------------------------------------------------------

Extensive in vitro characterization of the eight *S. cerevisiae* Rab GAPs has revealed biochemical preferences for specific Rab substrates (Table S1, available at <http://www.jcb.org/cgi/content/full/jcb.200801001/DC1>), but the in vivo functions of these GAPs are largely undefined. Yeast cells are viable when *GYP* genes are deleted individually, and only a fraction of the knockout mutants exhibit detectable vesicle-trafficking defects, probably because of functional redundancy ([@bib4]). As an alternative approach, we overproduced each of nine Gyp or Gyp-like proteins in cells. We then performed pulse-chase labeling with the styryl dye FM4-64 to examine vacuole morphology, a common indicator of endocytic trafficking defects ([Fig. 1 a](#fig1){ref-type="fig"}). Overproduction of Gyp1, Gyp5, or Gyl1 did not cause overt changes in vacuole morphology. Overproduction of Gyp2 and Gyp8 caused enlargement of the vacuole. In vitro, Gyp2 and Gyp8 stimulate GTP hydrolysis on Ypt6, which controls endosomal retrograde traffic, and on Sec4, which controls exocytosis of secretory vesicles. Thus, Gyp2 and Gyp8 may coordinate the inhibition of multiple Rabs within the cell to oppose secretion and retrograde endosomal traffic, shunting membrane to the vacuole. Gyp6, like Gyp2 and Gyp8, has an in vitro preference for Ypt6, but, unlike Gyp2 and Gyp8, it does not stimulate GTP hydrolysis on Sec4. Overproduction of Gyp6 caused accumulation of additional endosomal structures ([Fig. 1 a](#fig1){ref-type="fig"}), suggesting that Gyp6 more selectively opposes endosomal retrograde transport or endosome--vacuole fusion, as suggested by previous experiments ([@bib2]). Overproduction of three Gyps, Gyp3/Msb3, Gyp4/Msb4, and Gyp7, caused vacuoles to fragment, consistent with reduced vacuole fusion. Gyp3 and Gyp4 are implicated in polarized exocytosis and appear to be functionally redundant, although they have divergent in vitro Rab specificities (Table S1; [@bib9]). In vitro, both Gyp1 and Gyp7 inactivate Ypt7 and inhibit homotypic vacuole fusion ([@bib8]). However, Gyp7 overexpression in vivo caused vacuoles to fragment, whereas Gyp1 overexpression did not ([Fig. 1 a](#fig1){ref-type="fig"}). Thus, the in vitro selectivity of a Rab GAP is often, but not always, a reliable indicator of its in vivo functions. Our data suggest that Gyp7, and possibly Gyp3 and Gyp4, are bona fide negative regulators of Ypt7.

![**Gyp7 regulates vacuole morphology in vivo and in vitro.** (a) BY4742 wild-type *S. cerevisiae*--harboring plasmids expressing each of eight *GYP* paralogues, one *GYP*-like gene (Gyl1), or two catalytically inactive Gyp7 mutants (*GYP7-ΔTBC* or *GYP7-R458K*) behind a tetracycline-repressible promotor was grown in SC medium with (repressed) or without (expressed) 5 μM doxycycline. The cells were stained with the endocytic tracer FM4-64 as described in Materials and methods, and imaged. (b) BY4742 wild-type (*GYP7*) and *gyp7*Δ cells with or without a 2-μ plasmid overexpressing *GYP7* (+*GYP7*) were stained with FM4-64, exposed to hypotonic (water), isotonic (SC), or hypertonic (SC + 0.4 M NaCl) media for either 5 min (hypotonic) or 30 min (isotonic and hypertonic). Vacuole morphology was scored as either round or multilobed according to [@bib18]. 2,325 cells were analyzed. (c) Vacuoles isolated from BJ3505 and DKY2168 wild-type, *gyp7*Δ-, or *GYP7*-overexpressing yeast cells were incubated for 90 min in the presence of ATP and increasing concentrations of sorbitol, and homotypic vacuole fusion was measured. Similar results for *gyp7*Δ vacuoles were reported previously ([@bib5]). *n* ≥ 4 for all experiments shown. Error bars indicate mean ± SEM. Statistical significance is denoted by asterisks. \*, P ≤ 0.05; \*\*\*, P ≤ 0.001. Bars, 2 μm.](jcb1821141f01){#fig1}

In separate experiments, we uncovered a role for Gyp7 in vacuole fusion when hyperosmotic stress was applied to purified vacuoles in vitro ([@bib5]). Upon exposure of wild-type cells to hypotonic conditions, vacuoles fuse within seconds ([@bib3]; [@bib47], [@bib48]), whereas upon exposure to hypertonic medium, vacuoles fragment within minutes ([@bib3]; [@bib18]). We therefore assessed the in vivo consequences of *GYP7* overexpression or deletion on vacuole morphology in cells grown under various osmotic conditions ([Fig. 1 b](#fig1){ref-type="fig"}). The *gyp7*Δ deletion allele decreased fragmentation slightly but significantly under standard conditions ([Fig. 1 b](#fig1){ref-type="fig"}), whereas overexpression of *GYP7* from a high copy plasmid resulted in severely fragmented or multilobed vacuoles under all conditions, consistent with the idea that Gyp7 negatively regulates vacuole fusion in vivo ([Fig. 1 b](#fig1){ref-type="fig"}). Overexpression of *GYP7* in *gyp7*Δ mutant cells also increased vacuole fragmentation compared with wild-type cells. This fragmentation required Gyp7 with an intact catalytic TBC domain. Overexpression of Gyp7 lacking the TBC domain or with a mutated catalytic arginyl residue within the TBC domain (R458K) was without effect ([Fig. 1 a](#fig1){ref-type="fig"}, bottom). These results support the hypothesis that Gyp7 opposes Ypt7 action in vivo.

To further evaluate the role of Gyp7, we assayed the in vitro homotypic fusion of vacuoles isolated from *gyp7*Δ mutant and *GYP7* overexpressor cells ([Fig. 1 c](#fig1){ref-type="fig"}). In the standard assay of homotypic fusion, vacuoles are isolated from two yeast strains by equilibrium floatation: vacuoles from *pep4*Δ *PHO8* cells contain inactive alkaline phosphatase, proPho8, whereas vacuoles from *PEP4 pho8*Δ cells lack proPho8 but contain a maturase needed for Pho8 activation. Membrane fusion between the two types of vacuoles results in lumenal content mixing and Pho8 activation, which is then quantified with a colorimetric assay to obtain an index of fusion ([@bib51]; [@bib23]). Ypt7 inactivation occurs when vacuoles are exposed to hypertonic stress ([@bib5]). Vacuoles isolated from *gyp7*Δ cells were reduced in sensitivity to hypertonic stress; conversely, vacuoles isolated from *GYP7* overexpressors exhibited enhanced sensitivity to hypertonic stress ([Fig. 1 c](#fig1){ref-type="fig"}). Together, our results indicate that Gyp7 opposes Ypt7-dependent homotypic vacuole fusion both in vivo and in vitro.

Gyp7 inactivates Ypt7p in vivo
------------------------------

If Gyp7 modulates Ypt7 activity in vivo*,* we would expect that vacuoles isolated from *gyp7Δ* mutant or *GYP7* overexpressor cells should bear different amounts of active Ypt7, and fusion of these vacuoles should exhibit modified sensitivity to Ypt7 inhibitors. To test these predictions, we performed dose-inhibition studies ([Fig. 2 a](#fig2){ref-type="fig"}) with recombinant GDI1 (rGdi1), a Rab chaperone that inhibits fusion by preferentially extracting inactive Rab--GDP complexes from membranes. As predicted, vacuoles isolated from *gyp7*Δ cells were less sensitive to rGdi1 than vacuoles from wild-type cells, whereas vacuoles isolated from *GYP7* overexpressors were more sensitive to rGdi1 ([Fig. 2 a](#fig2){ref-type="fig"}). Similarly, vacuoles lacking Gyp7 were reduced in sensitivity to the recombinant catalytic domain of Rab-GAP Gyp1 (rGyp1~TBC~). In contrast, removal of endogenous Gyp7 did not alter dosage sensitivity to three inhibitors of fusion that do not target Ypt7: anti-Sec17 antibody, which blocks the early priming stage; anti-Vam3 antibody, which blocks SNARE function during docking; and MARCKS effector domain peptide, a late-stage inhibitor that chelates acidic lipid headgroups ([@bib46]; [@bib42]). To verify that rGyp1~TBC~ inhibits fusion by inhibiting Ypt7 and not some other target (e.g., another Rab) on the vacuole, we used a GTP-"locked" Ypt7 mutant, Ypt7~Q68L~, which exhibits an 85% reduction in both intrinsic and GAP-stimulated GTP hydrolysis in vitro ([@bib1]; [@bib44]; [@bib28]). In agreement with this result, in vitro fusion of vacuoles bearing Ypt7~Q68L~ was 80% less sensitive to rGyp1~TBC~ compared with vacuoles from wild-type cells ([Fig. 2 b](#fig2){ref-type="fig"}). Similarly, we found that the in vivo vacuole fragmentation caused by Gyp7 overproduction was suppressed by the *YPT7*~Q68L~ allele ([Fig. 2 c](#fig2){ref-type="fig"}). Collectively, these results demonstrate that endogenous Gyp7 decreases the amount of functionally active Ypt7 on the vacuole.

![**Gyp7 prevents vacuole fusion by inactivating Ypt7.** (a and b) Homotypic fusion was measured with vacuoles isolated from BJ3505 and DKY2168 wild-type (wt), *gyp7*Δ, *YPT7*~Q68L~, or *GYP7*-overexpressing cells (+*GYP7* 2μ). Vacuoles were incubated with ATP for 90 min in the presence of increasing concentrations of rGdi1 (a) or rGyp1~TBC~ (b). The mean fusion values were fit to sigmoidal dose--response curves (*r*^2^ \> 0.98). IC~50~ values for the fits are shown in parentheses. *n* ≥ 4 for all experiments shown. Error bars indicate mean ± SEM. (c) Wild-type DKY6128 cells containing chromosomal copies of wild-type *YPT7* or the GTP hydrolysis-deficient allele *YPT7*~Q68L~ in the presence or absence of *GYP7* expressed from a high copy 2-μm plasmid were grown in SC medium, stained with FM4-64, and imaged. Bar, 2 μm.](jcb1821141f02){#fig2}

To obtain a biochemical readout of the activation state of vacuolar Ypt7, we isolated vacuoles from *gyp7*Δ mutant cells or isogenic wild-type cells, incubated the vacuoles under fusion conditions, and briefly exposed them to rGdi1. Centrifugation was used to separate soluble from membrane pellet fractions ([Fig. 3 a](#fig3){ref-type="fig"}). Slightly more Ypt7 copurified with vacuoles from *gyp7*Δ cells compared with wild-type cells ([Fig. 3 a](#fig3){ref-type="fig"}, compare lane 1 with lane 3). Importantly, although rGdi1 extracted a majority of the Ypt7 on vacuoles isolated from wild-type cells, it extracted less than half of the Ypt7 on vacuoles from *gyp7*Δ cells ([Fig. 3 a](#fig3){ref-type="fig"}, compare lane 2 with lane 4; and [Fig. 3 b](#fig3){ref-type="fig"}, lane 1, 200-mM sorbitol condition). This result indicates that on vacuoles lacking Gyp7, an increased fraction of Ypt7 is in the active GTP-bound state. In addition, we examined the Ypt7 effector complex Vps-C/HOPS, which requires Ypt7 for its stable retention on the vacuole ([@bib8]; [@bib32]; [@bib38]). Like Ypt7, the HOPS subunit Vps41 was enriched on vacuoles isolated from *gyp7*Δ cells ([Fig. 3 a](#fig3){ref-type="fig"}), and a reduced fraction of Vps41 was released into the supernatant by rGdi1 treatment when Gyp7 was absent. Thus, the ratio of Ypt7:GTP to Ypt7:GDP is elevated on vacuoles obtained from *gyp7*Δ cells.

![**Native Gyp7 inactivates Ypt7p in vivo.** (a) Vacuoles isolated from BJ3505 wild type (*GYP7*) or *gyp7*Δ were incubated with ATP for 40 min with 9.5 μM rGdi1 absent or present during the last 10 min. Vacuoles were sedimented, and membrane association of Vps41, Vam3, and Ypt7 was assessed by immunoblotting. The white line indicates that intervening lanes have been spliced out. (b) Vacuoles isolated from BJ3505 wild-type (*GYP7*, top) or *gyp7*Δ cells (bottom) were pretreated with or without 200 μM GTPγS for 10 min at 27°C and incubated for 40 min with ATP in the presence or absence of 3.6 μM rGyp1~TBC~ at four concentrations of sorbitol (standard conditions). During the last 10 min of incubation, 9.5 μM rGdi1 was added. Vacuoles were immediately sedimented, and the membrane distribution of Ypt7 was assessed by immunoblotting. One third of the total isolated supernatant (S) and one fifth of the pellet (P) were analyzed by immunoblotting.](jcb1821141f03){#fig3}

We next examined Ypt7 activity in wild-type and *gyp7*Δ cells under physical conditions that increase or decrease Ypt7-mediated tethering and docking ([Fig. 3 b](#fig3){ref-type="fig"}). We recently found that Ypt7 is stabilized on membranes when the osmotic strength of the assay buffer is reduced ([@bib5]). A corresponding biochemical stabilization of Ypt7 was readily observed on vacuoles isolated from *gyp7*Δ versus *GYP7* cells as the sorbitol concentration was varied ([Fig. 3 b](#fig3){ref-type="fig"}, compare lanes 1). Endogenous Gyp7 therefore modulates the sensitivity of Ypt7 extraction to changes in osmotic strength.

Three observations indicate that Ypt7 stabilization on vacuoles lacking Gyp7 results from decreased GTP hydrolysis, not from increased nucleotide exchange or an intrinsic resistance of Ypt7 to Gdi1-mediated extraction. First, GTP was not normally added to our cell-free reactions ([Fig. 3, a and b](#fig3){ref-type="fig"}, lanes 1); thus, stabilization of active Ypt7 does not require nucleotide exchange. Second, addition of rGyp1~TBC~ resulted in almost complete extraction of Ypt7 under all conditions, indicating that unextracted Ypt7 is not intrinsically resistant to rGdi1 ([Fig. 3 b](#fig3){ref-type="fig"}, lanes 2). Third, and most importantly, preincubation of the vacuoles with GTPγS, a poorly hydrolyzable analogue of GTP, almost completely blocked Ypt7 extraction by rGdi1 ([Fig. 3 b](#fig3){ref-type="fig"}, lanes 3), indicating that Gdi1 is, as expected, preferentially extracting inactivated Ypt7. These findings were further supported by fusion experiments with rGdi1, rGyp1~TBC~, and GTPγS (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200801001/DC1>). Collectively, the results presented in [Figs. 1--3](#fig1){ref-type="fig"}[](#fig2){ref-type="fig"}[](#fig3){ref-type="fig"} establish Gyp7 as a major in vivo GAP of Ypt7.

Yck3p acts at the vacuole to oppose fusion
------------------------------------------

In addition to Gyp7, vacuole fusion is opposed by the casein kinase I Yck3 ([@bib18]). Yck3 localizes mainly to the vacuole, but it could oppose vacuole fusion either directly or indirectly (for example, by altering membrane recycling pathways). The latter possibility was a significant concern because Vps41, the only protein so far reported to be a target of Yck3, has been proposed to have roles in membrane budding as well as fusion ([@bib33]; [@bib32]). Yck3 requires ATP to function as a protein kinase, so we reasoned that removal of ATP should mimic the effects of Yck3 deletion. To test this idea, we exploited our finding that the recombinant SNARE rVam7 drives on pathway Rab- and SNARE-dependent fusion, bypassing the usual requirement for ATP and the Sec18 ATPase ([@bib24]; [@bib42]). Standard ATP-driven fusion reactions with vacuoles isolated from *yck3*Δ cells were highly resistant to rGdi1 when compared with reactions containing purified vacuoles from *YCK3* cells ([Fig. 4 a](#fig4){ref-type="fig"}), as reported previously ([@bib18]). In rVam7-driven ATP bypass reactions, however, there was no difference in rGdi1 sensitivity between vacuoles from *YCK3* and *yck3*Δ cells ([Fig. 4 b](#fig4){ref-type="fig"}). Comparable results were obtained using rGyp1~TBC~ instead of rGdi1 (unpublished data). Together, these results show that under conditions in which vacuolar Yck3 cannot operate, vacuoles from *YCK3* and *yck3*Δ strains have indistinguishable sensitivity to Rab inhibitors. With purified vacuoles, the effect of Yck3 manifests only under conditions in which the kinase can function, indicating that Yck3 must oppose Ypt7-stimulated fusion through immediate action on the vacuole, not through an indirect effect on membrane traffic.

![**Yck3 functions downstream of Ypt7 on the vacuole.** Vacuoles isolated from BY4742 *pep4*Δ and *pho8*Δ wild- type cells (*YCK3*) or *yck3*Δ cells were incubated with either ATP (a) or rVam7 (b) for 90 min in the presence of increasing concentrations of rGdi1. Fusion activity was measured and is shown as a fraction of the activity observed in the absence of rGdi1. Datasets were fit to sigmoidal dose--response curves (*r*^2^ \> 0.97); the IC~50~ values for the fits are shown in parentheses. Error bars indicate mean ± SEM. (c) BY4742 single or double mutant cells with the indicated genotypes were grown without (left) or with (right) the *GYP7* overexpression plasmid pYADH1-*GYP7*-His6 and stained with FM4-64 under isotonic conditions. Vacuole morphology was scored, and the fraction of cells with fragmented or multilobed vacuoles is indicated for each strain. 3,836 cells were analyzed. *n* ≥ 4 for all experiments shown. Bar, 3 μm.](jcb1821141f04){#fig4}

*YPT7* is epistatic to *YCK3*
-----------------------------

The mechanisms by which Ypt7 promotes fusion are unclear. The 30-fold greater resistance of in vitro fusion to Ypt7 inhibitors when Yck3 is absent raised the possibility that the main function of Ypt7-GTP is to counteract an inhibitory effect of Yck3. This model predicts that if Yck3 is removed, Ypt7 should not be needed for fusion. Conversely, if other functions of Ypt7 (such as propagating a positive signal through the Vps-C/HOPS complex) are essential, both Ypt7 and its effectors should be needed for fusion in both the presence and absence of Yck3. To test these predictions, we constructed double mutant cells lacking Yck3 and Ypt7, Vps39, or Vps41. We then examined vacuole morphology using FM4-64 dye loading ([Fig. 4 c](#fig4){ref-type="fig"}). In the absence of Ypt7, the FM4-64--labeled vacuolar compartment was fragmented in every cell examined, whether Yck3 was present or absent. We found a similar epistasis relationship in growth assays (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200801001/DC1>). Deletion of *YCK3* also failed to suppress vacuole morphology defects in cells lacking either of two major Ypt7-binding partners, the Vps-C/HOPS subunits Vps39 ([@bib52]) and Vps41 (see this paper). *YPT7*, *VPS39*, and *VPS41* are therefore epistatic to *YCK3*. Because the Rab and its binding partners are needed for fusion in both the presence and absence of Yck3, Yck3 appears to function as a modulator of the Ypt7 signaling pathway.

To test Yck3 function under conditions in which Ypt7 function is compromised but not eliminated, we performed an in vivo version of the in vitro experiment shown in [Fig. 4 a](#fig4){ref-type="fig"} by overexpressing *GYP7* in a *yck3*Δ mutant ([Fig. 4 c](#fig4){ref-type="fig"}). As shown in [Fig. 1](#fig1){ref-type="fig"}, *GYP7* overexpression in a wild-type cell caused vacuolar fragmentation. In sharp contrast, fragmentation did not increase when *GYP7* was overexpressed in *yck3*Δ mutant cells ([Fig. 4 c](#fig4){ref-type="fig"}). Thus, the in vivo and in vitro results are fully consistent and together reveal *YCK3* as a classical modifier. *YCK3* renders the *YPT7* pathway far more sensitive to inhibition, but removal of *YCK3* does not abrogate requirements for *YPT7*, *VPS39*, or *VPS41*.

Ypt7 opposes Yck3-mediated phosphorylation of Vps41 and Vam3
------------------------------------------------------------

We next sought biochemical correlates of the functional and genetic interactions among Ypt7, Vps41, Gyp7, and Yck3. It was shown previously that Vps41, a subunit of the Ypt7 effector complex Vps-C/HOPS, is phosphorylated in a reaction that requires *YCK3* ([@bib18]). This can be assayed by immunoblotting because phospho-Vps41 migrates slowly through SDS--polyacrylamide gels. Under standard in vitro vacuole fusion conditions, Vps41 phosphorylation was rapid and quantitative. Vps41 phosphorylation was inhibited, however, under conditions that activate or stabilize Ypt7, an effect readily observed when Gyp7 was absent ([Fig. 5 a](#fig5){ref-type="fig"}). Under standard reaction conditions ([Fig. 5 a](#fig5){ref-type="fig"}, 200 mM sorbitol, lane 1), most membrane-associated Vps41 was found in a slow-migrating band ([Fig. 5 a](#fig5){ref-type="fig"}, \*). However, the faster-migrating, nonphosphorylated form ([Fig. 5 a](#fig5){ref-type="fig"}, o) became more abundant when Ypt7 was further stabilized, either by preincubating the vacuoles with GTPγS ([Fig. 5 a](#fig5){ref-type="fig"}, compare 200 mM sorbitol, lanes 1 and 3) or by lowering the buffer osmotic strength ([@bib5]; [Fig. 5 a](#fig5){ref-type="fig"}, compare 200 mM with 100 mM sorbitol, lanes 1). The strongest inhibition of phosphorylation occurred when low osmolarity ([Fig. 5 a](#fig5){ref-type="fig"}, 100 mM sorbitol) and GTPγS were combined ([Fig. 5 a](#fig5){ref-type="fig"}, compare 100 mM sorbitol, lane 3 vs. 200 mM sorbitol, lane 1). Conversely, inactivation of Ypt7 with rGyp1~TBC~ enhanced Vps41 phosphorylation and dissociation from the membrane ([Fig. 5 a](#fig5){ref-type="fig"}, lanes 2). Ypt7-GTP therefore opposes Yck3-dependent phosphorylation of Vps41.

![**Ypt7-GTP opposes Yck3-mediated phosphorylation of Ypt7 targets.** (a) Vacuoles isolated from BJ3505 *gyp7*Δ cells were subjected to the same analysis as in [Fig. 3 b](#fig3){ref-type="fig"}, and the membrane distribution of Vps41 was assessed by immunoblotting. (b) Vacuoles isolated from BY4742 *pep4*Δ wild-type (*YCK3*) or *yck3*Δ cells were incubated for 70 min with or without ATP in the presence of increasing concentrations of sorbitol. Only standard conditions (200 mM sorbitol) are shown for *YCK3* vacuoles. Vacuoles were immediately sedimented, and membrane pellets were assayed for Vps41, Vam3, and Ypt7 by immunoblotting. (c) BY4742 *pep4*Δ vacuoles were incubated for 70 min with or without ATP in the presence or absence of three concentrations of CIP. Vacuoles were sedimented, and immunoblot analysis was performed on the membrane pellets to assess Vps41 and Vam3. (d) Vacuoles isolated from BY4742 *pep4*Δ wild-type (*YCK3*) or *yck3*Δ cells were incubated for 70 min with ATP in the presence or absence of 9.5 μM rGdi1 or 3.6 μM rGyp1~TBC~ at four concentrations of sorbitol. Vacuoles were sedimented, and immunoblot analysis was performed on the membrane pellets to assess Vps41 and Vam3. One fifth of the total membrane pellet was used for these analyses. Note the collapse of high M~r~ forms (\*) of Vps41 and Vam3 to the low M~r~ form (o) when GTPγS is present, sorbitol is decreased, *YCK3* is deleted, CIP is added, or rGdi1 is absent.](jcb1821141f05){#fig5}

The Q~a~-SNARE Vam3 is a core component of the vacuolar membrane fusion machinery and is essential for homotypic fusion. As with Vps41, we found that Vam3 is phosphorylated in a Yck3-dependent, Ypt7-inhibited reaction. ATP treatment resulted in slower Vam3 migration through SDS--polyacrylamide gels ([Fig. 5 b](#fig5){ref-type="fig"}, compare lane 9 with lane 10), and this observed change in Vam3 mobility is the result of phosphorylation. As previously reported for Vps41 ([@bib18]), slow-migrating Vam3 bands appeared only when ATP was supplied, and the slow-migrating bands for both Vps41 and Vam3 vanished upon exposure to alkaline phosphatase ([Fig. 5 c](#fig5){ref-type="fig"}). Slow-migrating, ATP-dependent phosphorylation products of both Vps41 and Vam3 appeared on vacuoles from *YCK3* cells but were absent on vacuoles from *yck3*Δ mutant cells ([Fig. 5 b](#fig5){ref-type="fig"}, compare lanes 1--8 with lanes 9 and 10; and [Fig. 5 d](#fig5){ref-type="fig"}). Moreover, Vam3 phosphorylation, like Vps41 phosphorylation, was opposed by Ypt7-GTP ([Fig. 5 d](#fig5){ref-type="fig"}), as inhibition of Ypt7 with rGdi1 in the presence or absence of rGyp1~TBC~ enhanced Vam3 phosphorylation at all sorbitol concentrations tested ([Fig. 5 d](#fig5){ref-type="fig"}, compare lanes 1 with lanes 2 and 3). Thus, at least two functional targets of Ypt7 (Vps41 and Vam3) are phosphorylated in Yck3-dependent reactions that occur on the vacuole, and phosphorylation of both targets is opposed by active Ypt7-GTP.

HOPS subunit Vps41 contains a Ypt7-binding site
-----------------------------------------------

The inhibition of Vps41 phosphorylation by activated Ypt7 ([Fig. 5](#fig5){ref-type="fig"}) raised the possibility that Ypt7 and Vps41 interact directly. The HOPS subunit Vps39 was reported to preferentially interact with unliganded Ypt7 and Ypt7-GDP ([@bib52]), but in other experiments, the HOPS holocomplex was selectively captured on Ypt7-GTPγS affinity resins ([@bib32]; [@bib38]). The divergent nucleotide specificities seen in these experiments suggested that the HOPS holocomplex might contain more than one Ypt7-binding site.

Fortuitously, a whole genome yeast two-hybrid screen for proteins that interact with the N-terminal region of Vps41 yielded only three strong hits from an ordered prey array of \>5,000 yeast ORFs: Ypt7, Vam3, and Csm3 (Fig. S3 a, available at <http://www.jcb.org/cgi/content/full/jcb.200801001/DC1>). In retests against a miniarray of independently constructed and validated prey constructs, the Vps41--Vam3 interaction was not consistently reproduced, but Vps41 and Ypt7 interacted robustly in every experiment ([Fig. 6](#fig6){ref-type="fig"}). The Ypt7 prey interacted with bait constructs containing either full-length Vps41 or an N-terminal fragment of Vps41 (residues 99--500), but Ypt7 failed to interact with bait constructs containing the C-terminal half of Vps41 (residues 501--992). Moreover, Vps41 failed to interact with a series of Ypt7 point mutants. In sharp contrast, Vps39 or N-terminal Vps39 fragments interacted with a broad spectrum of Ypt7 mutants ([Fig. 6](#fig6){ref-type="fig"}) and interacted more robustly with some mutant alleles of Ypt7 than with the wild-type construct. The preferential recognition of different Ypt7 alleles by Vps39 and Vps41 provides strong evidence that the binding sites of these proteins recognize different features or states of Ypt7.

![**A second Ypt7-binding site in Vps-C/HOPS subunit Vps41.** (a) Two-hybrid interaction tests were performed by mating cells harboring the indicated bait constructs against a miniarray of prey constructs as indicated, selecting for diploid cells, and replica plating the diploid cells to selective medium lacking histidine and containing 3-aminotriazole to increase stringency (see Materials and methods). The prey miniarray contains all 11 yeast Rab GTPases as well as mutant forms of Vps21 and Ypt7. The wild-type Ypt7 prey is indicated by a dashed circle. The Ypt7 or Vps21 mutants shown affect nucleotide binding; e.g., Ypt7-D129N and -I41S are predicted to have reduced affinity for both GDP and GTP. 2K and 6K mutants contain Arg substitutions at Lys residues reported to be ubiquitylated in native Ypt7 ([@bib17]). (b) Pull-down experiments were performed using eight different GST-Rab fusions or GST alone with cell lysates from BJ3505 Vps39-GFP cells. The amount of Vps41, Vps39-GFP, or Vps33 bound to the GST-Rab resin or found in lysate (load) was determined by immunoblotting. GST-Ypt11 is similar in size to Vps33, interfering with the migration of Vps33 in the Ypt11 lane. (c) Pull-down experiments were performed with either GST-Ypt7 or GST-Sec4 and lysates from BY4742 wild-type (wt), vps39Δ (*39*Δ), or *vps41*Δ (*41*Δ) cells in the presence of 200 μM GDP or GTPγS. Vps41 or Vps33 in the load and eluate fractions was detected by immunoblotting. (d) Pull-down experiments were performed with either GST-Ypt7 or GST-Sec4 resins and 200-nM recombinant full-length Vps41 (rVps41) in the presence of 200 μM GDP or GTPγS. Input and bound proteins were separated by SDS-PAGE and stained with Coomassie brilliant blue.](jcb1821141f06){#fig6}

In previous studies ([@bib32]; [@bib38]; [@bib52]; [@bib18]), Vps39 and HOPS were shown to bind Ypt7 preferentially over Vps21 and Ypt1, but binding to the other eight yeast Rab proteins has not previously been evaluated. We found that neither Vps39 nor Vps41 interacted strongly with any yeast Rab other than Ypt7, indicating a high degree of binding selectivity. In an additional control performed to verify the specificity of the prey miniarray, Vac1, a known effector of the endosomal Rab Vps21, interacted with Vps21 and an activated Vps21 allele (Fig. S3 b) but not with Ypt7 or any other yeast Rab.

To further scrutinize Ypt7--Vps41 interactions, we performed affinity pull-down experiments using yeast cell lysates and resins decorated with GST-Rab fusion proteins. Consistent with our results from two-hybrid experiments ([Fig. 6 a](#fig6){ref-type="fig"}), Vps41 was retained on GST-Ypt7--GTPγS but not on seven other GST-Rab--GTPγS affinity matrices. The other component of HOPS known to bind Ypt7 directly, Vps39, exhibited a similar selectivity for Ypt7 over other Rabs in these experiments. Vps33, a component of both the Vps-C/HOPS and Vps-C/CORVET complexes, controls traffic to the prevacuolar endosome ([@bib29]). Vps33 bound to Ypt7 preferentially, but it also bound other Rabs to a lesser extent, including the endosomal Rab Vps21 ([Fig. 6 b](#fig6){ref-type="fig"}). Together with our yeast two-hybrid results, these results demonstrate for the first time that Vps-C/HOPS interacts quite selectively with Ypt7 but not with any other *S. cerevisiae* Rab.

We next examined the relative contributions of Vps39 and Vps41 in the binding of HOPS to Ypt7 ([Fig. 6 c](#fig6){ref-type="fig"}). This experiment is possible because *vps39*Δ and *vps41*Δ mutant cells contain stable hybrid Vps-C complexes in which Vps39 or Vps41 are replaced by Vps3 or Vps8 ([@bib29]). As reported previously, the HOPS holocomplex preferentially bound Ypt7 in the presence of GTPγS ([Fig. 6 c](#fig6){ref-type="fig"}; [@bib32]; [@bib38]; [@bib29]). In the absence of Vps39, however, HOPS binding to Ypt7 declined substantially, and the apparent nucleotide selectivity was lost ([Fig. 6 c](#fig6){ref-type="fig"}). In the absence of Vps41, HOPS binding to Ypt7 was undetectable, demonstrating that Vps41 is essential for stable Ypt7-HOPS binding. To test whether Ypt7 and Vps41 interact directly, pull-down experiments were performed using purified recombinant proteins. Consistent with the two hybrid assays ([Fig. 6 a](#fig6){ref-type="fig"}) and results obtained using lysates from *vps39*Δ cells ([Fig. 6 c](#fig6){ref-type="fig"}), full-length Vps41 bound to Ypt7 but not to Sec4. The Vps-C/HOPS complex therefore contains a minimum of two distinct and highly selective Ypt7-binding sites: one site resides in the presumed GEF, Vps39, and a second site resides in the N-terminal portion of Vps41.

Discussion
==========

A great deal is known about the enzymology of Rab regulation, but far less is known about how Rabs are regulated in the context of cellular physiology. The present experiments delineate a pathway that enforces the tight coupling of a membrane docking and fusion machinery to the activation state of its cognate Rab GTPase ([Fig. 7](#fig7){ref-type="fig"}). First, we show that the Rab7 paralogue Ypt7, which controls fusion at the lysosomal vacuole of budding yeast, is inactivated in vivo by a cognate GAP, Gyp7, confirming a relationship previously implied by in vitro assays with purified proteins ([@bib44]; [@bib8]; [@bib28]). Second, we show that the casein kinase Yck3 acts directly at the vacuole as a downstream negative regulator of Ypt7 signaling. Third, we show that the Gyp7 GAP cannot efficiently terminate Ypt7 signaling in the absence of Yck3 in vivo. Fourth, we show that activated Ypt7-GTP acts to block Yck3-dependent phosphorylation of at least two of its own functional targets: the HOPS subunit Vps41 and the Vam3 SNARE. Finally, we demonstrate that Vps41 contains a Ypt7-binding site and is essential for stable HOPS binding to Ypt7.

![**Feed-forward inhibition of Ypt7 signaling.** (a) General scheme. (b) Implementation at the yeast vacuole. Lines terminating in arrows indicate positive regulation, and lines terminating in bars indicate inhibition. Vps39 and Vps41 are subunits of the Vps-C/HOPS protein complex, which also contains Vps11, 16, 18, and 33.](jcb1821141f07){#fig7}

In our working model ([Fig. 7](#fig7){ref-type="fig"}), the signaling state of Ypt7 is controlled by an activating GEF (probably Vps39; [@bib52]) and an inhibitory GAP (Gyp7), whereas the coupling of downstream functions to Ypt7 activation is enforced by the Yck3 kinase, which inhibits Rab targets, increasing the amount of activated Rab required to generate a functional output (fusion). Moreover, the activated Ypt7 Rab itself opposes Yck3-mediated phosphorylation of Rab signaling targets. When the Rab is inactive, downstream functions are inhibited; when the Rab is active, it prevents inhibitory phosphorylation, and downstream functions are not inhibited. In the absence of the kinase, the Rab\'s downstream effectors are uninhibited, and even residual Rab signaling is sufficient to promote fusion.

Obviously, aspects of this working model are tentative. For example, the functional consequences of Yck3-dependent Vam3 phosphorylation are not yet characterized. However, Ungermann and colleagues have identified the site of Yck3-mediated phosphorylation within Vps41 and have confirmed that modification of this site inhibits Vps41 function (Ungermann, C., personal communication). At present, activated Ypt7-GTP is the only signal transducer known to regulate Yck3-dependent phosphorylation ([Fig. 5](#fig5){ref-type="fig"}). Ypt7-GTP could oppose Yck3-dependent phosphorylation by directly or indirectly inhibiting the intrinsic activity of Yck3 or by activating or localizing a phosphatase. Alternatively, Ypt7 could shield substrates from the Yck3 kinase through direct binding interactions, a possibility supported by our discovery that Vps41, a Yck3 target, also contains a Ypt7-binding site ([Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}).

Our data further suggest that a positive feedback loop controls activation of Ypt7 in a manner similar to that described for Rab5, its GEF Rabex-5, and its effector Rabaptin ([@bib19]). Vps39, the Ypt7 GEF ([@bib52]), and Vps41 are physically associated as subunits of the Vps-C/HOPS tethering complex ([@bib38]), and both subunits are necessary for specific binding of the HOPS holocomplex to Ypt7 in the presence of GTPγS ([Fig. 6 c](#fig6){ref-type="fig"}). Vps39-mediated activation of Ypt7 would generate additional binding sites for HOPS, thereby further stabilizing HOPS at the membrane and allowing Vps39 to engage in multiple cycles of Ypt7 activation ([Fig. 7 b](#fig7){ref-type="fig"}). Studies of Ypt7-regulated protein localization at vacuole-docking junctions provide additional support for the existence of a Vps39-mediated positive feedback loop ([@bib46]). Because Vps41 is needed for stable HOPS binding to Ypt7, we predict that inactivation of Vps41 by Yck3 will terminate this positive feedback, reducing the efficacy of Vps39-mediated Ypt7 activation. Experimental tests of these predictions are underway in our laboratory.

There are several examples of phosphorylation regulating Rab signaling pathways. The Rab GAP AS160 ([@bib36]) regulates insulin-stimulated exocytosis of glucose transporters. When phosphorylated by Akt, AS160 is inhibited, permitting activation of its target, Rab10 ([@bib35]; [@bib37]). Phosphorylation also regulates downstream targets of Rabs, including SNARE proteins, in both yeast and mammals. For example, casein kinase II phosphorylates the synaptic Q~a~-SNARE syntaxin 1A in vitro ([@bib15]). Phosphorylation often inversely correlates with fusion. Yeast cells expressing a Golgi Q~a~-SNARE Sed5 phosphomimetic mutant have fragmented Golgi compartments, whereas cells expressing a phosphorylation-resistant Sed5 mutant have ordered Golgi ([@bib12]; [@bib49]). Rab effectors are also phosphorylated ([@bib20]; [@bib21]). For example, phosphorylation of the Rab11 effector Rip11 controls its localization on apical recycling endosomes within epithelial cells ([@bib31]). Finally, the Ypt31/32 Rab GTPases regulate phosphorylation of the yeast R-SNARE Snc1 ([@bib6]). Thus, interactions between Rab signaling and phosphorylation are pervasive.

A general problem in biological signal transduction is the maintenance of fidelity in circuits that, because they rely on small populations of molecules, operate in a noisy analogue mode. In these systems, negative feedbacks are used to maintain homeostatic equilibria, whereas positive feedbacks can amplify small signals or generate switchlike behaviors. We propose that the Ypt7 signaling pathway incorporates both a positive feedback loop that reinforces Ypt7 activation and a positive feed-forward loop (which uses two negative elements in series) that enforces the requirement for Ypt7 activation ([Fig. 7](#fig7){ref-type="fig"}). We propose that this circuit topology increases the fidelity of Ypt7-mediated signaling by suppressing spurious downstream signaling when an upstream signal falls below a specific threshold. This in turn renders the overall pathway more responsive to signals that impinge on Ypt7 by increasing the pathway\'s signal to noise ratio. Given the commonality of other strategies in small GTPase signaling ([@bib11]; [@bib4]), it is likely that such an arrangement will not be unique to the vacuolar Rab.

Note added in proof.
--------------------

We have identified conditions under which purified Vps41 binds selectively to Ypt7-GTPγS. To obtain homogenous Ypt7-GDP, GST-Ypt7 bound to ∼50 μl of glutathione-agarose beads is incubated with 5 μg His~6~-Gyp1~TBC~ overnight at 4°C and for 30 min at 23°C. The Gyp1 is removed. GST-Ypt7-GTPγS is prepared from GST-Ypt7-GDP by incubating the bead suspension for 90 min at 23°C in nucleotide exchange buffer (50 mM Tris-Cl, pH 8.0, 100 mM NaCl, 4 mM EDTA, and 5 mM 2-mercaptoethanol) containing 1.4 mM GTPγS. GTPγS loading is stopped by the addition of excess pull-down buffer (50 mM Tris-Cl, pH 8.0, 100 mM NaCl, 5 mM MgCl~2~, and 5 mM 2-mercaptoethanol). The beads are washed twice in pull-down buffer, and Vps41 pull-down is performed as in [Fig. 6 d](#fig6){ref-type="fig"}.

Materials and methods
=====================

Strains and plasmids
--------------------

For fusion assays, we used complimentary strain pairs of BJ3505 (*MAT*α *pep4*∷*HIS3 prb1-1.6R his3-200 lys2-801 trp1-101* \[*gal3*\] *ura3-52 gal2 can1*) and DKY6281 (*MAT*α *leu2-3 leu2-112 ura3-52 his3-200 trp1-901 lys2-801*) or BY4742 *pep4*Δ (*MAT*α *ura3*Δ *leu2*Δ *his3*Δ *lys2*Δ *pep4*Δ*∷neo* \[Invitrogen\]) and BY4742 *pho8*Δ*∷neo*. BJ3505 *GFP-VPS39*, BJ3505 *gyp7*Δ∷*URA3*, DKY6281 *gyp7*Δ∷*URA3* or BJ3505 *YPT7*~Q68L~∷*neo*, and DKY6281 *YPT7*~Q68L~∷*neo* were provided by W. Wickner (Dartmouth College, Hanover, NH), G. Eitzen (University of Alberta, Edmonton, Canada), and D. Gallwitz (Max Planck Institute of Biophysical Chemistry, Göttingen, Germany). Double mutant *yck3*Δ *pep4*Δ (AMY807), *yck3*Δ *pho8*Δ (AMY809), *yck3*Δ *ypt7*Δ (AMY913), *yck3*Δ *vps41*Δ (AMY996), or *yck3*Δ *vps39*Δ (AMY999) cells were constructed by mating BY4741 (*MAT*α *ura3*Δ *leu2*Δ *his3*Δ *met15*Δ \[Invitrogen\]) with BY4742-derived haploid cells and sporulating; the genotypes of spores isolated by tetrad dissection were confirmed by mapping PCR. Gyp7-overproducing BY4742 wild-type, *gyp7*Δ, *ypt7*Δ, *yck3*Δ, *yck3*Δ*ypt7*Δ and BJ3505, DKY6281, or DKY6281 *YPT7*~Q68L~ cells carried the plasmid pYADH1-*GYP7*-His~6~ (*GYP7* with a C-terminal hexahistidine tag inserted behind the *ADH1* promoter in the 2-μ yeast shuttle vector \[39967; American Type Culture Collection\] D. Gallwitz). The set of regulated *GYP* plasmids was constructed by gap repair--mediated homologous recombination between the vector pCM190 (containing a tetracycline-repressible promotor; [@bib10]), and each of the eight *GYP* genes or *GYL1* (a *GYP*-like gene) was amplified by PCR with primers containing terminal sequences homologous to pCM190. The resulting plasmids were rescued into *Escherichia coli*, amplified, sequenced, and transformed into *S. cerevisiae* BY4742. Transformants were selected in the presence of doxycycline and in the absence of uracil. Gyp overproduction was induced by removing doxycycline from the growth medium.

Reagents
--------

All biochemical reagents were purchased from Sigma-Aldrich or Invitrogen, except as indicated, and were of biotechnology grade or better. The endoglucanase fraction of Zymolyase (20T; Seikigaku) was purified by cation exchange chromatography before use in vacuole isolation. Calf intestinal phosphatase (CIP) was purchased from New England Biolabs, Inc. Purified proteins used include rGdi1 purified from bacterial cells using a calmodulin-binding peptide intein fusion system (provided by V. Starai, Dartmouth Medical School, Hanover, NH; and W. Wickner), rGyp1~TBC~, recombinant soluble Qc-SNARE Vam7, and recombinant protease inhibitor Pbi2. Rabbit polyclonal sera raised against Vps41, Vps33, Ypt7, and Vam3 (provided by W. Wickner) were affinity purified and, in some cases, were cross-adsorbed against cell lysates from corresponding yeast deletion strains to reduce cross-reactivity. The protein reagents used in fusion assays were prepared in 10 mM Pipes-KOH, pH 6.8, and 200 mM sorbitol (Pipes-sorbitol buffer, PS) or were exchanged into this buffer by dialysis or size exclusion chromatography.

Fusion
------

Vacuoles were purified as described previously by [@bib13]. 6 μg of isolated vacuoles was incubated for 90 min at 27°C in standard reaction buffer as follows: PS buffer supplemented with salts (0.5 mM MgCl~2~ and 125 mM KCl), 10 mM CoA, and Pbi2 with or without ATP-regenerating system (0.5 mM ATP, 0.1 mg/ml creatine kinase, and 40 mM creatine phosphate). Bypass fusion was initiated with 100 nM rVam7 in the presence of 1 mg/ml BSA. Osmotic gradients were imposed by reducing or adding sorbitol to the standard isotonic reaction buffer (200 mM sorbitol). As indicated, reactions also contained CIP, rGdi1, rGyp1~TBC~, or GTPγS. The total volume of each fusion reaction was 30 μl. Fusion reactions were conducted using DKY6128 (or BY4742 *pho8*Δ; alkaline phosphatase deficient) and BJ3505 (or BY4742 *pep4*Δ; protease deficient) vacuoles (3 μg each) with or without genomic deletion of *GYP7* (*gyp7*Δ) or *YCK3* (*yck3*Δ), with *YPT7 or YPT7*~Q68L~, or expression of pYADH1-*GYP7*-His~6~ (+*GYP7*). Homotypic vacuole fusion was measured using a biochemical complementation assay ([@bib13]; [@bib23]). Fusion (content mixing) was quantified by monitoring the alkaline phosphatase--catalyzed evolution of *p*-nitrophenolate at 400 nm. Signals were then subtracted from a background control reaction either lacking ATP or incubated on ice; the signal to background ratio under our standard conditions routinely exceeds 25:1. Results are reported relative to signals obtained under standard fusion conditions (200 mM sorbitol with ATP or rVam7). Under standard conditions, the mean extent of fusion was 4.11 ± 0.12 (*n* = 16) fusion units as previously defined ([@bib13]; [@bib23]). Vacuole membrane release or the phosphorylation state of Ypt7, Vam3, and HOPS components was determined using fusion reactions containing exclusively protease-deficient vacuoles (6 μg BJ3505 or BY4742 *pep4*Δ). After incubation at 27°C for 40 or 70 min, fusion reactions were immediately sedimented by centrifugation at 20,000 *g* for 5 min at 4°C. Pellet and supernatant fractions were separated by SDS-PAGE and analyzed by immunoblotting as indicated.

Microscopy
----------

To assess vacuole morphology in vivo, yeast were incubated for 1 h at 30°C in synthetic complete (SC) medium containing 3 μM FM4-64, sedimented, and resuspended in SC. After a 30-min chase period, cells were sedimented again, resuspended in either water, SC, or SC supplemented with 0.4 M NaCl, incubated for 5 or 30 min at 30°C, and imaged. To quantify cellular vacuole morphology phenotypes, at least six micrographs containing fields of ∼30 cells (from three independent cultures) were acquired, and cellular vacuole morphology was visually classified as either round or multilobed using the scheme of [@bib18]; [Fig. 1 b](#fig1){ref-type="fig"}). Cells were scored as "round" if vacuoles were present as a single large or small spherical structure, a single large spherical structure with small adjoining vesicles, or two large oblong abutting structures. Cells were scored as "multilobed" (or fragmented) if they contained three or more small spherical structures or a single tubular structure with one or more spherical structures. All micrographs were acquired using a microscope (IX71; Olympus) equipped with an electron-multiplying charge-coupled device (iXon; Andor), ultrabright green and blue light-emitting diodes (\>350-mW output) driven by custom electronics, a PlanApoN 1.45 NA 60× objective lens, and iQ software (version 6.0.3.62; Andor). Micrographs were processed using ImageJ (version 1.36b; National Institutes of Health) and Photoshop CS (version 8.0; Adobe) software. The images shown were adjusted for brightness and contrast and sharpened with an unsharp masking filter.

Two-hybrid tests
----------------

Parent strains and plasmids were obtained from the University of Washington Yeast Resource Center. Two-hybrid plasmid constructs were constructed in haploid yeast strains by PCR-mediated homologous recombination cloning. ORF or domain sequences were amplified by PCR using primers containing terminal homology to the two-hybrid test vectors. Prey domains were cloned into gapped pOAD plasmid by cotransformation into the yeast strain PJ69-4 *MAT*α. Bait domains were cloned into pOBD2 in strain PJ69-4 *MAT*α. Clonal isolates were verified by PCR and DNA sequencing. Interaction tests were performed by mating bait and prey haploid strains. Liquid cultures of the bait and prey strains were grown in selective media, mixed in 96-well plates, and pinned to yeast extract--peptone--dextrose plates supplemented with adenine using a 48-spoke inoculating manifold. These mating plates were grown at 30°C overnight, and diploids were selected by replica plating onto medium lacking tryptophan and leucine and supplemented with adenine. Diploid colonies were grown at 30°C for 2 d, replica plated to medium lacking tryptophan, leucine, and histidine, and supplemented with adenine and 1.5 mM 3-amino-1,2,4-triazole. After 5 d at 30°C, the plates were scored for growth.

GST-Rab pull-down assays
------------------------

GST or GST-Rab fusion proteins were expressed in *E. coli* BL21-pRIL cells transformed with the vector pGST-Parallel-1 or with the same vector containing in-frame NcoI--BamHI PCR products encoding full-length Rab genes. Fusion proteins were coupled to glutathione--Sepharose 4B resin (GE Healthcare) as described previously for Ypt7 ([@bib32]), except coupling was performed in the absence of EDTA and EGTA, and 5 mM MgCl~2~ was present throughout. Nucleotide loading of Rab proteins was performed by incubating Rab-bound resin in exchange buffer (50 mM Tris-HCl, pH 8.5, 100 mM NaCl, 0.01% 2-mercaptoethanol, 5 mM MgCl~2~, and 500 μM guanine nucleotide) for 30 min. 50 μl of packed, nucleotide-loaded GST-Rab resin was incubated with 500 μl of vacuole lysates, whole cell lysates, or recombinant Vps41 for 2 h. The resin was washed five times with 500 μl of lysis or solubilization buffer, and bound proteins and GST-Rabs were eluted by boiling reactions in 1× SDS buffer for 10 min. Equal loading of glutathione resins with Rab proteins was confirmed by SDS-PAGE. Whole cell lysates were similarly prepared as vacuoles, but after spheroplasting, cells were resuspended in lysis buffer (20 mM Hepes-KOH, pH 7.4, 50 mM potassium acetate, 200 mM sorbitol, 0.01% 2-mercaptoethanol, 5 mM MgCl~2~, 0.7 μg/ml leupeptin, 0.5 μg/ml pepstatin, and 1 mM PMSF) and lysed by Dounce homogenization on ice. The lysate was solubilized with 1% Triton X-100 and clarified by centrifugation (20,000 *g* for 15 min). 500 μg of lysate protein was then added to the resin. Vacuole lysates were prepared by sedimenting 300 μg of isolated vacuoles (20,000 *g* for 10 min), resuspending membrane pellets in 500 μl of solubilization buffer (25 mM Hepes-KOH, pH 7.4, 125 mM NaCl, 10% glycerol, 0.5% Triton X-100, 5 mM MgCl~2~, 0.01% 2-mercaptoethanol, and protease inhibitors), and clarifying soluble lysates by centrifugation (13,000 *g* for 10 min). Except as noted, all experiments were performed on ice or at 4°C.

Preparation of recombinant Vps41
--------------------------------

His~6~-tagged Vps41 was expressed in Tn-5B1-4 (High-5) insect cells using the Bac-to-Bac system (Invitrogen). An in-frame BamH1--KpnI PCR product encoding full-length Vps41 was inserted into the shuttle vector pFB-HTB-N. The resulting plasmid was sequenced and transformed into DH10Bac *E. coli,* and bacmid DNA was purified from this strain. Bacmid DNA was transfected into Sf9 cells to prepare first, second, and third generation multiple nuclear polyhedrosis baculovirus stocks. Suspension-adapted High-5 cells were infected with virus, grown in suspension using SF-900 II serum-free media, supplemented with 100 U/ml penicillin, 10 μg/ml streptomycin, and 0.11 μg/ml [l]{.smallcaps}-glutamine for 72 h at 27°C, and harvested. Cell pellets were washed three times in PBS, resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 350 mM NaCl, and 5 mM 2-mercaptoethanol), and lysed by sonication. Lysates were clarified by centrifugation (18,000 *g* for 20 min), incubated with pre-equilibrated nickel-nitrilotriacetic acid resin (GE Healthcare) for 1 h, and eluted using lysis buffer supplemented with 350 mM imidazole. The resulting eluate was size fractionated and exchanged into storage buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM 2-mercaptoethanol, and 10% glycerol) on a Superdex 200 column (GE Healthcare). Aliquots of Vps41 were frozen in thin-walled PCR tubes by immersion in liquid nitrogen.

Data analysis
-------------

Where applicable, datasets were fit to sigmoidal dose--response functions using a nonlinear least-squares algorithm. Log IC~50~ values were extracted from the sigmoidal fits using Prism software (version 4.0c; GraphPad Software, Inc.). Data are reported as mean ± SEM. Mean comparisons were performed using Student\'s two-tailed *t* tests with corrections for multiple comparisons.

Online supplemental material
----------------------------

Table S1 shows a summary of in vitro Rab specificities of the nine yeast Rab-GAP proteins. Fig. S1 shows that addition of GTP or GTPγS to vacuole fusion reactions overcomes inhibition of Ypt7 by rGdi1 or rGyp1TBC. Fig. S2 shows that deletion of *YCK3* is unable to suppress poor growth of *ypt7*Δ yeast at high temperatures. Fig. S3 shows a complete list of Vps41-interacting proteins obtained from our genome-wide yeast two-hybrid screen and control data validating the use of our two-hybrid miniarrays to evaluate Rab-binding selectivity. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200801001/DC1>.
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